Clinical Observation on 126 Cases of Early Threatened Abortion Treated by Zhixue Baotai Yin

doi:10.13288/j.11-2166/r.2005.02.018

您当前的位置：

首页 >

文章列表页 >

Clinical Observation on 126 Cases of Early Threatened Abortion Treated by Zhixue Baotai Yin

更新时间：2021-11-20

- Clinical Observation on 126 Cases of Early Threatened Abortion Treated by Zhixue Baotai Yin
- Journal of Traditional Chinese Medicine Issue 2, Pages: 116-118(2005)
- 作者机构：
  
  1. 宁夏回族自治区银川市妇幼保健院中医科
  2. 宁夏医学院附属医院妇产科银川市文化西街16号,750001
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2005.02.018
  CLC： R271.4
- Published：2005
- 稿件说明：
移动端阅览
[1]宋雅丽,赵亚琼,张雪玉.止血保胎饮治疗早期先兆流产患者126例临床观察[J].中医杂志,2005(02):116-118.

Clinical Observation on 126 Cases of Early Threatened Abortion Treated by Zhixue Baotai Yin[J]. Journal of Traditional Chinese Medicine2005, (2): 116-118.
[1]宋雅丽,赵亚琼,张雪玉.止血保胎饮治疗早期先兆流产患者126例临床观察[J].中医杂志,2005(02):116-118. DOI： 10.13288/j.11-2166/r.2005.02.018.

Clinical Observation on 126 Cases of Early Threatened Abortion Treated by Zhixue Baotai Yin[J]. Journal of Traditional Chinese Medicine2005, (2): 116-118. DOI： 10.13288/j.11-2166/r.2005.02.018.

摘要

目的:从早期先兆流产的人绒毛膜促性腺激素（HCG）、促黄体激素（LH）动态变化观察中药止血保胎饮的保胎效果。方法:对已出现阴道流血的243例早期先兆流产患者进行 HCG、LH 动态监测

并随机分为治疗组（126例）和对照组（117例）

分别给予中药止血保胎饮和黄体酮保胎

对两组疗效进行比较。结果:治疗组治愈97例

保胎率76.98%;对照组治愈51例

保胎率43.59%

治疗组保胎成功率明显高于对照组（P<0.01）。初查 HCG、LH 低于同期妊娠正常值者经治疗后

治疗组52例流产24例

流产率46.15%;对照组49例流产45例

流产率91.84%。治疗组流产率明显低于对照组（P<0.01）。结论:在提高内分泌激素水平、缓解症状、增强体质、改善盆腔环境、促进宫体和胚胎的供血供氧及保胎方面

中药明显优于黄体酮;HCG、LH 动态监测为诊断内分泌因素流产、保胎治疗及判断是否终止妊娠提供了依据和新思路。

Abstract

Objective:To observe effect of Zhixue Baotai Yin in maintaining pregnancy in early threatened abortion.Methods:HCG and LH were monitored dynamically in 243 cases of early threatened abortion with colporrhagia.They were randomly divided into a treatment group（n=126）and a control group（n=117）

and were respectively treated with Zhixue Baotai Yin and progesterone. Their therapeutic effects were compared.Results:97 cases were cured in the treatment group with the fetus-protective rate of 76.98%

and 51 cases in the control group with the fetus protective rate of 43.59%

with a significant difference between the two groups（P<0.01）.Of 52 cases with HCG and LH lower than normal value at same pregnancy stage in the treatment group

24 cases aborted

the abortion rate being 46.15% and of 49 cases in control group

45 cases aborted

the abortion rate being 91.84%. The abortion rate in the treatment group was significantly lower than that in control group（P<0.01）.Conclusion:Zhixue Baotai Yin in increasing hormone level

alleviating symptoms

strengthening constitution

protecting fetus and others is superior to progesterone;and dynamic monitor of HCG and LH can provide a basis for diagnosis of abortion due to hormone factors

treatment of protecting fetus and judgment of stopping pregnancy.

关键词

Keywords

references

查看原文

Views

218

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical Efficacy and Economic Evaluation of 1293 Non-Severe Adult Patients with Community-Acquired Pneumonia Treated by the Jiangsu Traditional Chinese Medicine Diagnosis and Treatment Protocol for Dominant Diseases：A Multicenter，Retrospective Real-World Cohort Study

Construction and Application of a Real-World Cohort of Community-Acquired Pneumonia Based on a Multimodal Large-Scale Traditional Chinese Medicine Big Data Platform

LI Guolie's Experience in Treating Orthostatic Hypotension from the Perspective of "Raising the Clear and Directing the Turbid Downward"

A Preliminary Discussion on the Method of Regulating Qi and Calming the Mind

WANG Qingguo's Experience in Treatment of Headache Based on the Concept of "Achieving Harmony by Unblocking and Balancing"

Related Author

No data

Related Institution

No data

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰